×
Adjunctive Modafinil at Initiation of Treatment With a Selective Serotonin Reuptake Inhibitor Enhances the Degree and Onset of Therapeutic Effects in Patients With Major Depressive Disorder and Fatigue PDF
$ 40.00
Adjunctive Modafinil at Initiation of Treatment With a Selective Serotonin Reuptake Inhibitor Enhances the Degree and Onset of Therapeutic Effects in Patients With Major Depressive Disorder and Fatigue PDF quantity
$ 40.00
×
Risk of Arrest in Persons With Schizophrenia and Bipolar Disorder in a Florida Medicaid Program: The Role of Atypical Antipsychotics, Conventional Neuroleptics, and Routine Outpatient Behavioral Health Services PDF
$ 40.00
Risk of Arrest in Persons With Schizophrenia and Bipolar Disorder in a Florida Medicaid Program: The Role of Atypical Antipsychotics, Conventional Neuroleptics, and Routine Outpatient Behavioral Health Services PDF quantity
$ 40.00
×
Long-Term Maintenance Therapy With Quetiapine Versus Haloperidol Decanoate in Patients With Schizophrenia or Schizoaffective Disorder PDF
$ 40.00
Long-Term Maintenance Therapy With Quetiapine Versus Haloperidol Decanoate in Patients With Schizophrenia or Schizoaffective Disorder PDF quantity
$ 40.00
×
Concomitant Medications May Not Improve Outcome of Antipsychotic Monotherapy for Stabilized Patients With Nonacute Schizophrenia. PDF
$ 40.00
Concomitant Medications May Not Improve Outcome of Antipsychotic Monotherapy for Stabilized Patients With Nonacute Schizophrenia. PDF quantity
$ 40.00
×
Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression: A Controlled Study of SSRI and Nortriptyline Resistance PDF
$ 40.00
Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression: A Controlled Study of SSRI and Nortriptyline Resistance PDF quantity
$ 40.00
×
First Episode of Self-Harm in Older Age: A Report From the 10-Year Prospective Manchester Self-Harm Project PDF
$ 40.00
First Episode of Self-Harm in Older Age: A Report From the 10-Year Prospective Manchester Self-Harm Project PDF quantity
$ 40.00
×
An 8-Week, Randomized Controlled Trial of Atomoxetine, Atomoxetine Plus Buspirone, or Placebo in Adults With ADHD PDF
$ 40.00
An 8-Week, Randomized Controlled Trial of Atomoxetine, Atomoxetine Plus Buspirone, or Placebo in Adults With ADHD PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart